• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低蛋白饮食的慢性肾脏病患者能量摄入较低与心血管死亡率风险升高相关。

Lower energy intake associated with higher risk of cardiovascular mortality in chronic kidney disease patients on a low-protein diets.

机构信息

School of Laboratory Medicine, Chengdu Medical College, Chengdu, 610500, China.

Department of Nephrology, Jinniu Hospital, Sichuan Provincial People's Hospital, Jinniu People's Hospital, Chengdu, 610072, China.

出版信息

Nutr J. 2024 Jul 15;23(1):75. doi: 10.1186/s12937-024-00980-y.

DOI:10.1186/s12937-024-00980-y
PMID:39004744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247864/
Abstract

OBJECTIVE

An increasing number of studies shown that inadequate energy intake causes an increase in adverse incidents in chronic kidney disease (CKD) patients on low-protein diets (LPD). The study aimed to investigate the relationship between energy intake and cardiovascular mortality in CKD patients on a LPD.

METHODS

This was a cross-sectional study, a total of 4264 CKD patients were enrolled from the NHANES database between 2009 and 2018. Restricted cubic spline plots and Cox regression analysis were used to analyze the association between energy intake and cardiovascular mortality in CKD patients on a LPD. Additionally, a nomogram was constructed to estimate cardiovascular survival in CKD patients on a LPD.

RESULTS

Among CKD patients on a LPD in the United States, 90.05% had an energy intake of less than 25 kcal/kg/day, compared to 36.94% in CKD patients on a non-LPD. Energy intake and cardiovascular mortality showed a linear relationship in CKD patients on a LPD, while a 'U-shaped' relationship was observed in CKD patients on a non-LPD. Multifactorial Cox regression models revealed that for Per-standard deviation (Per-SD) decrement in energy intake, the risk of cardiovascular mortality increased by 41% (HR: 1.41, 95% CI: 1.12, 1.77; P = 0.004) in CKD patients on a LPD. The concordance index of the nomogram was 0.79 (95% CI, 0.75, 0.83).

CONCLUSION

CKD patients, especially those on a LPD, have significantly inadequate energy intake. Lower energy intake is associated with higher cardiovascular mortality in CKD patients on a LPD.

摘要

目的

越来越多的研究表明,能量摄入不足会增加接受低蛋白饮食(LPD)治疗的慢性肾脏病(CKD)患者的不良事件发生率。本研究旨在探讨 LPD 治疗的 CKD 患者能量摄入与心血管死亡率之间的关系。

方法

这是一项横断面研究,共纳入了 2009 年至 2018 年 NHANES 数据库中的 4264 例 CKD 患者。采用受限立方样条图和 Cox 回归分析来分析 LPD 治疗的 CKD 患者能量摄入与心血管死亡率之间的关系。此外,还构建了一个列线图来估计 LPD 治疗的 CKD 患者的心血管生存情况。

结果

在美国接受 LPD 治疗的 CKD 患者中,有 90.05%的患者能量摄入低于 25 kcal/kg/天,而接受非 LPD 治疗的 CKD 患者中这一比例为 36.94%。LPD 治疗的 CKD 患者中,能量摄入与心血管死亡率呈线性关系,而非 LPD 治疗的 CKD 患者中则呈“U 型”关系。多因素 Cox 回归模型显示,对于 LPD 治疗的 CKD 患者,每标准偏差(Per-SD)的能量摄入减少,心血管死亡率的风险增加 41%(HR:1.41,95%CI:1.12,1.77;P=0.004)。列线图的一致性指数为 0.79(95%CI,0.75,0.83)。

结论

CKD 患者,尤其是接受 LPD 治疗的患者,能量摄入明显不足。较低的能量摄入与 LPD 治疗的 CKD 患者心血管死亡率升高有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/0e8fc52334e5/12937_2024_980_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/c80a15359b80/12937_2024_980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/7589e5f510f9/12937_2024_980_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/d95e87b8cd86/12937_2024_980_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/d5f5a94334ae/12937_2024_980_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/20d9bb4f4824/12937_2024_980_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/0e8fc52334e5/12937_2024_980_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/c80a15359b80/12937_2024_980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/7589e5f510f9/12937_2024_980_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/d95e87b8cd86/12937_2024_980_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/d5f5a94334ae/12937_2024_980_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/20d9bb4f4824/12937_2024_980_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3699/11247864/0e8fc52334e5/12937_2024_980_Fig6_HTML.jpg

相似文献

1
Lower energy intake associated with higher risk of cardiovascular mortality in chronic kidney disease patients on a low-protein diets.低蛋白饮食的慢性肾脏病患者能量摄入较低与心血管死亡率风险升高相关。
Nutr J. 2024 Jul 15;23(1):75. doi: 10.1186/s12937-024-00980-y.
2
The association between low protein diet and body composition, muscle function, inflammation, and amino acid-based metabolic profile in chronic kidney disease stage 3-5 patients.低蛋白饮食与慢性肾脏病 3-5 期患者的身体成分、肌肉功能、炎症和基于氨基酸的代谢特征之间的关系。
Clin Nutr ESPEN. 2021 Dec;46:405-415. doi: 10.1016/j.clnesp.2021.08.037. Epub 2021 Oct 4.
3
Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010.单核细胞-淋巴细胞比值与慢性肾脏病患者全因和心血管死亡率的关系:来自 2003-2010 年全国健康和营养调查(NHANES)的数据分析。
Ren Fail. 2024 Dec;46(1):2352126. doi: 10.1080/0886022X.2024.2352126. Epub 2024 Jun 4.
4
Association of the American Heart Association's new "Life's Essential 8" with all-cause mortality in patients with chronic kidney disease: a cohort study from the NHANES 2009-2016.美国心脏协会的新“生命必需 8 项”与慢性肾脏病患者全因死亡率的关联:来自 NHANES 2009-2016 的队列研究。
BMC Public Health. 2024 Jun 19;24(1):1637. doi: 10.1186/s12889-024-19138-w.
5
Dietary intake of luteolin is negatively associated with all-cause and cardiovascular mortality in chronic kidney disease patients.类黄酮的饮食摄入量与慢性肾脏病患者的全因死亡率和心血管死亡率呈负相关。
BMC Public Health. 2024 Jul 30;24(1):2044. doi: 10.1186/s12889-024-19458-x.
6
No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial.在常规肾脏病学护理下,对于晚期慢性肾脏病患者,开具极低蛋白饮食并无额外获益:一项实用的、随机的、对照试验。
Am J Clin Nutr. 2022 May 1;115(5):1404-1417. doi: 10.1093/ajcn/nqab417.
7
Vitamin K intake and mortality in people with chronic kidney disease from NHANES III.NHANES III 中慢性肾脏病患者的维生素 K 摄入量与死亡率。
Clin Nutr. 2015 Apr;34(2):235-40. doi: 10.1016/j.clnu.2014.03.011. Epub 2014 Apr 2.
8
Protein restriction for diabetic kidney disease.限制蛋白质摄入治疗糖尿病肾病。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
9
An investigation of low-protein diets' qualification rates and an analysis of their short-term effects for patients with CKD stages 3-5: a single-center retrospective cohort study from China.一项针对中国 CKD 3-5 期患者低蛋白饮食合格率及其短期效果的调查:一项单中心回顾性队列研究。
Int Urol Nephrol. 2023 Apr;55(4):1059-1070. doi: 10.1007/s11255-022-03390-3. Epub 2022 Oct 31.
10
Which low-protein diet for which CKD patient? An observational, personalized approach.哪种低蛋白饮食适合哪种慢性肾脏病患者?一种观察性的个性化方法。
Nutrition. 2014 Sep;30(9):992-9. doi: 10.1016/j.nut.2014.01.004. Epub 2014 Jan 25.

本文引用的文献

1
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病中的糖尿病管理:美国糖尿病协会 (ADA) 和改善全球肾脏病预后组织 (KDIGO) 的共识报告。
Kidney Int. 2022 Nov;102(5):974-989. doi: 10.1016/j.kint.2022.08.012. Epub 2022 Oct 3.
2
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病中的糖尿病管理:美国糖尿病协会(ADA)和改善全球肾脏病预后组织(KDIGO)的共识报告。
Diabetes Care. 2022 Dec 1;45(12):3075-3090. doi: 10.2337/dci22-0027.
3
Epidemiology of chronic kidney disease: an update 2022.
慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
4
Compliance, Adherence and Concordance Differently Predict the Improvement of Uremic and Microbial Toxins in Chronic Kidney Disease on Low Protein Diet.依从性、坚持性和一致性对低蛋白饮食的慢性肾脏病患者尿毒症毒素和微生物毒素改善情况的预测作用不同。
Nutrients. 2022 Jan 23;14(3):487. doi: 10.3390/nu14030487.
5
Impact of Inadequate Calorie Intake on Mortality and Hospitalization in Stable Patients with Chronic Heart Failure.热量摄入不足对稳定期慢性心力衰竭患者死亡率和住院率的影响。
Nutrients. 2021 Mar 8;13(3):874. doi: 10.3390/nu13030874.
6
New predictive equations to estimate resting energy expenditure of non-dialysis dependent chronic kidney disease patients.用于估计非透析依赖性慢性肾脏病患者静息能量消耗的新预测方程。
J Nephrol. 2021 Aug;34(4):1235-1242. doi: 10.1007/s40620-020-00899-7. Epub 2021 Feb 11.
7
SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus.钠-葡萄糖协同转运蛋白 2 抑制剂(SGLT2i)作为二线治疗药物与 2 型糖尿病患者的死亡率、终末期肾病和心血管疾病风险的相关性。
Diabetes Metab. 2021 Jul;47(4):101196. doi: 10.1016/j.diabet.2020.09.005. Epub 2020 Oct 8.
8
INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats.INT-777 通过 TGR5/cAMP/PKA 信号通路减轻大鼠蛛网膜下腔出血后 NLRP3-ASC 炎性小体介导的神经炎症。
Brain Behav Immun. 2021 Jan;91:587-600. doi: 10.1016/j.bbi.2020.09.016. Epub 2020 Sep 19.
9
KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update.KDIGO 临床实践指南:慢性肾脏病中的营养治疗 2020 年更新版。
Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006.
10
Screening for chronic kidney disease: moving toward more sustainable health care.慢性肾脏病筛查:迈向更可持续的医疗保健。
Curr Opin Nephrol Hypertens. 2020 May;29(3):333-338. doi: 10.1097/MNH.0000000000000597.